People news

Share this article:
Oscient Pharmaceuticals promoted Mark Glickman to SVP, sales and marketing and corporate officer. Glickman was VP sales and is credited with the growth of the company's lead product, Antara capsules. 

Nektar Therapeutics announced the appointment of Randall Moreadith, MD, PhD, to SVP, drug development and chief development officer. Moreadith will report to Nektar's president and CEO, Howard W. Robin.

Management consulting firm Campbell Alliance announced the appointment of Nader Naeymi-Rad as COO. Naeymi-Rad was formerly a SVP and head of the firm's brand management practice. Darius Naigamwalla has assumed that position.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media